Role of the Chromosome Architectural Factor SMCHD1 in X-Chromosome Inactivation, Gene Regulation, and Disease in Humans
- PMID: 31420322
- PMCID: PMC6781896
- DOI: 10.1534/genetics.119.302600
Role of the Chromosome Architectural Factor SMCHD1 in X-Chromosome Inactivation, Gene Regulation, and Disease in Humans
Abstract
Structural maintenance of chromosomes flexible hinge domain-containing 1 (SMCHD1) is an architectural factor critical for X-chromosome inactivation (XCI) and the repression of select autosomal gene clusters. In mice, homozygous nonsense mutations in Smchd1 cause female-specific embryonic lethality due to an XCI defect. However, although human mutations in SMCHD1 are associated with congenital arhinia and facioscapulohumeral muscular dystrophy type 2 (FSHD2), the diseases do not show a sex-specific bias, despite the essential nature of XCI in humans. To investigate whether there is a dosage imbalance for the sex chromosomes, we here analyze transcriptomic data from arhinia and FSHD2 patient blood and muscle cells. We find that X-linked dosage compensation is maintained in these patients. In mice, SMCHD1 controls not only protocadherin (Pcdh) gene clusters, but also Hox genes critical for craniofacial development. Ablating Smchd1 results in aberrant expression of these genes, coinciding with altered chromatin states and three-dimensional (3D) topological organization. In a subset of FSHD2 and arhinia patients, we also found dysregulation of clustered PCDH, but not HOX genes. Overall, our study demonstrates preservation of XCI in arhinia and FSHD2, and implicates SMCHD1 in the regulation of the 3D organization of select autosomal gene clusters.
Keywords: HOX genes; SMCHD1; X-chromosome inactivation; chromatin; clustered protocadherin genes; epigenetics.
Copyright © 2019 by the Genetics Society of America.
Figures
Similar articles
-
FSHD2- and BAMS-associated mutations confer opposing effects on SMCHD1 function.J Biol Chem. 2018 Jun 22;293(25):9841-9853. doi: 10.1074/jbc.RA118.003104. Epub 2018 May 10. J Biol Chem. 2018. PMID: 29748383 Free PMC article.
-
SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of variants in the ATPase domain.J Med Genet. 2019 Oct;56(10):693-700. doi: 10.1136/jmedgenet-2019-106168. Epub 2019 Jun 26. J Med Genet. 2019. PMID: 31243061 Free PMC article.
-
Many faces of SMCHD1.Nat Genet. 2017 Jan 31;49(2):176-178. doi: 10.1038/ng.3776. Nat Genet. 2017. PMID: 28138148
-
The Epigenetic Regulator SMCHD1 in Development and Disease.Trends Genet. 2017 Apr;33(4):233-243. doi: 10.1016/j.tig.2017.01.007. Epub 2017 Feb 20. Trends Genet. 2017. PMID: 28222895 Review.
-
Clinical report of Bosma arhinia microphthalmia syndrome with a new variant on SMCHD1 gene. A case report.Endocrinol Diabetes Nutr (Engl Ed). 2024 Mar;71(3):138-143. doi: 10.1016/j.endien.2024.03.011. Endocrinol Diabetes Nutr (Engl Ed). 2024. PMID: 38555111 Review.
Cited by
-
Derivation of a minimal functional XIST by combining human and mouse interaction domains.Hum Mol Genet. 2023 Apr 6;32(8):1289-1300. doi: 10.1093/hmg/ddac285. Hum Mol Genet. 2023. PMID: 36426827 Free PMC article.
-
DUX4 double whammy: The transcription factor that causes a rare muscular dystrophy also kills the precursors of the human nose.Sci Adv. 2023 Feb 17;9(7):eabq7744. doi: 10.1126/sciadv.abq7744. Epub 2023 Feb 17. Sci Adv. 2023. PMID: 36800423 Free PMC article.
-
Contribution of genetic and epigenetic changes to escape from X-chromosome inactivation.Epigenetics Chromatin. 2021 Jun 29;14(1):30. doi: 10.1186/s13072-021-00404-9. Epigenetics Chromatin. 2021. PMID: 34187555 Free PMC article.
References
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous